Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment

  • Original Article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Hemifacial spasm (HFS) is a chronic disease that is characterized by involuntary tonic and clonic contractions of the muscles innervated by the ipsilateral facial nerve. Botulinum toxin (BTX) is the most effective medical treatment of this condition. The aim of our study was to evaluate stigma among patients diagnosed with HFS and to search quality of life and depression before and after BTX injection. Seven self-rating items (HFS-7) and seven questions related to stigmatization were administered to HFS patients. Participants also answered SF-36 health outcome measure and Beck depression inventory before and 4 weeks after the routine BTX injection. The severity of HFS was graded based on a five-point scale. Descriptive statistics and paired t test were applied. The level of significance was set at α = 0.05. Fourty HFS patients were prospectively included. Twenty-one (%52.5) were female and nineteen were male (47.5%) with a mean age of 57.1 (SD = 12.13; min–max = 27–78). 60% (n: 24) of patients were feeling themselves different from people without HFS. Beck depression inventory scores improved after BTX injection significantly (p < 0.05). All domains of SF-36 showed positive improvement after BTX injections. The improvement in general health perception, physical functioning, and vitality was statistically significant (p < 0.05). Although more than half of the patients felt themselves different from people without HFS, treatment of HFS with BTX significantly improved mental health and physical health, and depressive symptoms of the patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chaudhry N, Srivastava A, Joshi L. Hemifacial spasm: the past, present and future. J Neurol Sci (2015). https://doi.org/10.1016/j.jns.2015.06.032

    Article  PubMed  Google Scholar 

  2. Abbruzzese G, Berardelli A, Defazio G (2011) Hemifacial spasm. Handb Clin Neurol 100:675–680. https://doi.org/10.1016/B978-0-444-52014-2.00048-3

    Article  PubMed  Google Scholar 

  3. Tan EK, Fook-Chong S, Lum SY et al (2004) Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci 219:151–155

    Article  CAS  PubMed  Google Scholar 

  4. Tan EK, Chan LL, Koh KK et al (2005) Behind the facial twitch: depressive symptoms in hemifacial spasm. Parkinsonsim Relat Disord 11:241–245

    Article  Google Scholar 

  5. Ak PD, Atakli D, Yuksel B et al (2015) Stigmatization and social impacts of epilepsy in Turkey. Epilepsy Behav 50:50–54

    Article  PubMed  Google Scholar 

  6. Van der Beek KM, Bos I, Middel B et al (2013) Experienced stigmatization reduced quality of life of patients with a neuromuscular disease: a cross-sectional study. Clin Rehabil 27(11) 1029–1038

    Article  PubMed  Google Scholar 

  7. Scambler G (1998) Stigma and disease: changing paradigms. Lancet 352:1054–1055

    Article  CAS  PubMed  Google Scholar 

  8. Gray AJ (2002) Stigma in psychiatry. J R Soc Med 95(2):72–76

    Article  PubMed  PubMed Central  Google Scholar 

  9. Çam O, Çuhadar D (2012) Bipolar bozukluğu olan hastalarda işlevsellik düzeyi ve damgalama arasındaki ilişkinin belirlenmesi. Gümüşhane Üniversitesi Sağlık. Bilimleri Dergisi 2:230–246

    Google Scholar 

  10. Çam O, Bilge A (2013) Türkiye’de Ruhsal Hastalığa/Hastaya Yönelik İnanç, Tutum ve Damgalama Süreci: Sistematik Derleme. Psikiyatri Hemşireliği Dergisi J Psychiatr Nurs 4(2):91–101

    Article  Google Scholar 

  11. Huang YC, Fan JY, Ro LS, Lyu RK, Chang HS, Chen ST, Hsu WC, Chen CM, Wu YR (2009) Validation of a Chinese version of disease specific quality of life scale (HFS-36) for hemifacial spasm in Taiwan. Health Qual Life Outcomes 7:104. https://doi.org/10.1186/1477-7525-7-104

    Article  PubMed  PubMed Central  Google Scholar 

  12. Prisnie JC, Sajobi TT, Wang M, Patten SB, Fiest KM, Bulloch AGM, Pringsheim T, Wiebe S, Jette N (2018) Effects of depression and anxiety on quality of life in five common neurological disorders. Gen Hosp Psychiatry 52:58–63. https://doi.org/10.1016/j.genhosppsych.2018.03.009 (epub 2018 Apr 4)

    Article  PubMed  Google Scholar 

  13. Singh S (2013) Botulinum toxin in hemifacial spasm: revisited. Indian J Plast Surg 46(1):159–160

    Article  PubMed  PubMed Central  Google Scholar 

  14. Yaltho TC, Jankovic J (2011) The many faces of hemifacial spasm: differential diagnosis of unilateral fcial spasms. Mov Disord 26(9):1582–1592. https://doi.org/10.1002/mds.23692 (epub 2011 Apr 5)

    Article  PubMed  Google Scholar 

  15. Jankovic J, Schwartz K, Donovan DT (1990) Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 53:633–639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Tan EK, Fook-Chong S, Lum SY, Thumboo J (2005) Validation of a short disease specific quality of life scale for hemifacial spasm: correlation with SF-36. J Neurol Neurosurg Psychiatry 76(12):1707–1710

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ware JE Jr, Snow KK, Kosinski M et al (1993) SF-36 Health Survey manuel and interpretation guide. Nimrod, Boston

    Google Scholar 

  18. Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A (1999) Kısa form-36 (KF36)’nın Türkçe versiyonunun güvenirliliği ve geçerliliği. İlaç ve Tedavi Dergisi 12(2):102–106

    Google Scholar 

  19. Hisli N (1989) Beck Depresyon envanterinin üniversite öğrencileri için geçerliği, güvenirliği. Psikoloji dergisi 7:3–13

    Google Scholar 

  20. Scambler G (1989) Epilepsy. Tavistock, London

    Google Scholar 

  21. McCagh J (2009) Epilepsy, psychosocial and cognitive functioning. Epilepsy Res 86:1–14

    Article  PubMed  Google Scholar 

  22. Suurmeijer TP, Reuvekamp MF, Aldenkamp BP (2001) Social functioning, psychological functioning, and quality of life in epilepsy. Epilepsia 42(9):1160–1168

    Article  CAS  PubMed  Google Scholar 

  23. Rusch N, Angermeyer MC, Corrigan PW (2005) Mental illness stigma: concepts, consequences, and initiatives to reduce stigma. Eur Psychiatry 20(8):529–539

    Article  PubMed  Google Scholar 

  24. Alonso J, Buron A, Bruffaerts R et al (2008) Association of per- ceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys. Acta Psychiatr Scand 118(4):305–314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Kyra M, van der Beek, Bos I, Middel B, Wynia K (2013) Experienced stigmatization reduced quality of life of patients with a neuromuscular disease: a cross-sectional study. Clin Rehabil 27(11) 1029–1038. https://doi.org/10.1177/0269215513487234

    Article  Google Scholar 

  26. Josh WH, Kohl A (2001) Botulinum toxin: evidence based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 248:21–24 (Suppl.)

    Article  Google Scholar 

  27. Streitová H, Bareš M (2014) Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years. Acta Neurol Belg 114(4):285–291. https://doi.org/10.1007/s13760-014-0285-z (epub 2014 Mar 7)

    Article  PubMed  Google Scholar 

  28. Jinnah HA, Berardelli A, Comella C, Defazio G, Delong MR, Factor S, Galpern WR, Hallett M, Ludlow CL, Perlmutter JS, Rosen AR, Dystonia Coalition Investigators (2013) The focal dystonias: current views and challenges for future research. Mov Disord 28(7):926–943. https://doi.org/10.1002/mds.25567

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Defazio G, Abbruzzese G, Livrea P, Berardelli A (2004) Epidemiology of primary dystonia. Lancet Neurol 3:673–678

    Article  PubMed  Google Scholar 

  30. Broocks A, Thiel A, Angerstein D, Dressler D (1998) Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. Am J Psychiatry 155(4):555–557

    Article  CAS  PubMed  Google Scholar 

  31. Bao F, Wang Y, Liu J, Mao C, Ma S, Guo C, Ding H, Zhang M (2015) Structural changes in the CNS of patients with hemifacial spasm. Neuroscience 289:56–62. https://doi.org/10.1016/j.neuroscience.2014.12.070 (epub 2015 Jan 14)

    Article  CAS  PubMed  Google Scholar 

  32. Shimizu M, Suzuki Y, Kiyosawa M, Wakakura M, Ishii K, Ishiwata K, Mochizuki M (2012) Glucose hypermetabolism in the thalamus of patients with hemifacial spasm. Mov Disord 27(4):519–525. https://doi.org/10.1002/mds.24925 (epub 2012 Feb 16)

    Article  PubMed  Google Scholar 

  33. Tan EK, Chan LL, Koh KK (2004) Coexistent bepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism? J Neurol Neurosurg Psychiatry 75:494–496

    Article  PubMed  PubMed Central  Google Scholar 

  34. Dias FM, Doyle F, Kummer A, Cardoso F, Fontenelle LF, Teixeira AL (2010) Frequency of psychiatric disorders in blepharospasm does not differ from hemifacial spasm. Acta Neuropsychiatr 22:223–227. https://doi.org/10.1111/j.1601-5215.2009.00436.x

    Article  PubMed  Google Scholar 

  35. Rudzińska M, Wójcik M, Malec M et al (2012) Factors affecting the quality of life in hemifacial spasm patients. Neurol Neurochir Pol 46(2):121–129

    Article  Google Scholar 

  36. Setthawatcharawanich S, Aui-aree N, Limapichart K, Satirapunya P, Phabphal K (2008) The validation of the disease-specific questionnaire for health-related quality of life in Thai patients with hemifacial spasm. J Med Assoc Thai 91(11):1691–1697

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Ass. Prof. Dilek Atakli for sharing her questions related to stigmatization and Prof. Hakan Yaman for his contribution.

Funding

No funding was received for this study. This research did not receive any grant from funding agencies.

Author information

Authors and Affiliations

  1. Neurology Department, Antalya Training and Research Hospital, Muratpasa, 07050, Antalya, Turkey

    Burcu Yuksel, Fatma Genc, Aylin Yaman, Eylem Ozaydin Goksu & Yasemin Bicer Gomceli

  2. Neurology Department, Fatih Sultan Mehmet Training and Research Hospital, Kadıkoy, 34752, Istanbul, Turkey

    Pelin Dogan Ak

Authors
  1. Burcu Yuksel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatma Genc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aylin Yaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eylem Ozaydin Goksu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pelin Dogan Ak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasemin Bicer Gomceli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Burcu Yuksel.

Ethics declarations

Conflict of interest

There is nothing to declare as a competing interest for any of the authors including the corresponding author.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by ethics committee and informed consent was obtained from all individual participants included in the study.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuksel, B., Genc, F., Yaman, A. et al. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment. Acta Neurol Belg 119, 55–60 (2019). https://doi.org/10.1007/s13760-018-1018-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-018-1018-5

Keywords

Search

Navigation